SCHEMBL5037437

SCHEMBL5037437

COc1cc(F)c(C(OC)C(=O)NCc2ccc(C(=N)NC(=O)OC(C)(C)C)cc2)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
EPHX2 P34913 2/20 0.38
NR1H4 Q96RI1 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 2/20 0.36
KLKB1 P03952 1/20 0.36
MASP2 O00187 1/20 0.36
HDAC1 Q13547 1/20 0.35
ALDH1A1 P00352 3/20 0.35
F2 P00734 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NAMPT P43490 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5043478 0.84 MASP2 (0.47) NPC1RAB9AKMT2APKMMAPT
SCHEMBL5041447 0.83 F2 (0.48) PKMMASP2ALDH1A1F2TDP1
SCHEMBL5041146 0.83 F2 (0.48) PKMMASP2ALDH1A1F2TDP1
SCHEMBL5043621 0.83 F2 (0.48) PKMMASP2ALDH1A1F2TDP1
Hydrochloric Acid SCHEMBL5041002 0.82 F2 (0.48) PKMMASP2ALDH1A1F2TDP1
Hydrochloric Acid SCHEMBL5040997 0.82 F2 (0.48) PKMMASP2ALDH1A1F2TDP1
SCHEMBL5037719 0.81 PKM (0.36) NPC1RAB9AEPHX2NR1H4L3MBTL1
SCHEMBL5041412 0.81 PKM (0.36) NPC1RAB9AEPHX2NR1H4L3MBTL1
SCHEMBL5037718 0.81 PKM (0.36) NPC1RAB9AEPHX2NR1H4L3MBTL1
SCHEMBL5037434 0.81 PKM (0.36) NPC1RAB9AEPHX2NR1H4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US claimed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US claimed
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 NPC1 3616/4885RAB9A 124/4885EPHX2 1557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.